Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BOM:524548's ROA % is ranked better than 61.97% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.81
vs BOM:524548: 4.05
Sharma East India Hospitals & Medical Research (BOM:524548) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Sharma East India Hospitals & Medical Research ROA % Related Terms
Sharma East India Hospitals & Medical Research ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sharma East India Hospitals & Medical Research ROA % Chart
Sharma East India Hospitals & Medical Research Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sharma East India Hospitals & Medical Research ROA % vs Healthcare Providers & Services Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Sharma East India Hospitals & Medical Research (BOM:524548) has a ROA % of 5.22% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sharma East India Hospitals & Medical Research and its competitors. This is 74% above median its historical median of 3.00. Over the past decade, Sharma East India Hospitals & Medical Research's ROA % has ranged from 0.49 to 4.71. According to the industry distribution chart, Sharma East India Hospitals & Medical Research ranks #259 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 38%.
Is Sharma East India Hospitals & Medical Research's ROA % too high?
Sharma East India Hospitals & Medical Research's current ROA % of 5.22% is 74% above median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 4.71. The Healthcare Providers & Services industry median ROA % is 1.81. Sharma East India Hospitals & Medical Research's value of 5.22% is 188.4% above this industry median. Based on the distribution chart, Sharma East India Hospitals & Medical Research ranks #259 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sharma East India Hospitals & Medical Research has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sharma East India Hospitals & Medical Research's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sharma East India Hospitals & Medical Research ranks #259 out of 681 companies for ROA %. This puts Sharma East India Hospitals & Medical Research in the upper half of its industry. The industry median ROA % is 1.81. Sharma East India Hospitals & Medical Research's value of 5.22% is 188.4% above this benchmark. Historically, Sharma East India Hospitals & Medical Research's own ROA % has ranged from 0.49 to 4.71 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 1.81, Sharma East India Hospitals & Medical Research has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.81, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sharma East India Hospitals & Medical Research's current ROA % of 5.22% is 188.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Sharma East India Hospitals & Medical Research and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sharma East India Hospitals & Medical Research's current ROA % is 5.22%, which is 74% above median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sharma East India Hospitals & Medical Research stock overvalued right now?
Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research (BOM:524548) is currently considered Fairly Valued. The stock's GF Value™ is ₹101.98, compared to a current price of ₹99.78 — trading 2.2% below its estimated fair value. The current ROA % is 5.22%, which is 74% above median its 10-year median of 3.00 and 188.4% above the Healthcare Providers & Services industry median of 1.81. Sharma East India Hospitals & Medical Research's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Sharma East India Hospitals & Medical Research (BOM:524548), the current ROA % is 5.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sharma East India Hospitals & Medical Research (BOM:524548) Overvalued in 2026?
Based on GuruFocus' analysis, Sharma East India Hospitals & Medical Research stock appears to be undervalued.
The current stock price of ₹99.78 is trading 2.2% below its estimated GF Value™ of ₹101.98.
GuruFocus considers Sharma East India Hospitals & Medical Research to be Fairly Valued.
Key valuation signals for BOM:524548:
ROA %: 5.22% (74% above median its 10-year median of 3.00)
GF Value™: ₹101.98 vs. price of ₹99.78 (2.2% below fair value)
Industry Position: 188.4% above the Healthcare Providers & Services median (#259 of 681)
No single metric tells the full story. See the BOM:524548 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sharma East India Hospitals & Medical Research Business Description
Sharma East India Hospitals & Medical Research Ltd is engaged in service activities related to the medical and healthcare services and real estate services. It provides healthcare services through the multi-specialty hospital in the name of Jaipur Hospital in Rajasthan. It provides services like joint replacement surgery, arthroscopy, cardiothoracic and vascular surgery, interventional cardiology, such as angiography and angioplasty, neurosurgery, and others.
77GF Score
Get the complete analysis for BOM:524548
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524548 has been successfully added to your 
